News
Today is a big day in drugs. It’s when the US Food and Drug Administration shuts down an emergency measure that allows pharmacies to sell copies of the most widely prescribed weight-loss injection.
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
The Trump administration announced it will not finalize a rule proposed by the Biden administration that would have allowed ...
Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...
While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...
Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...
FuturHealth offers both compounded semaglutide and FDA-approved name-brand options like Wegovy and Ozempic. For most users, ...
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
The top reasons weight loss supplements fail and why most solutions don't address both day and night fat-burning cycles; How PhenQ works as a powerful daytime fat burner to help r ...
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results